Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
10.9M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
2.05M
-
Shares change
-
-5.48K
-
Total reported value, excl. options
-
$4.81M
-
Value change
-
-$27.4K
-
Number of buys
-
4
-
Number of sells
-
-10
-
Price
-
$2.35
Significant Holders of AYTU BIOPHARMA, INC - Common Stock (AYTU) as of Q3 2024
27 filings reported holding AYTU - AYTU BIOPHARMA, INC - Common Stock as of Q3 2024.
AYTU BIOPHARMA, INC - Common Stock (AYTU) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.05M shares
of 10.9M outstanding shares and own 18.83% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (1.09M shares), Stonepine Capital Management, LLC (501K shares), ARMISTICE CAPITAL, LLC (236K shares), RENAISSANCE TECHNOLOGIES LLC (74.7K shares), GEODE CAPITAL MANAGEMENT, LLC (45.1K shares), VANGUARD GROUP INC (27.9K shares), BlackRock, Inc. (22.8K shares), DIMENSIONAL FUND ADVISORS LP (21.8K shares), ACADIAN ASSET MANAGEMENT LLC (14.6K shares), and NORTHERN TRUST CORP (14.6K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.